994-P: Clinical Study of a New Extended Wear Infusion Set
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes"
DOI: 10.2337/db20-994-p
Abstract: Objective: Current real-time continuous glucose monitoring (CGM) sensors are approved for 7-14 days of wear, whereas insulin infusion sets are indicated for 2-3 days of wear. Development of a closed-loop control system with the same… read more here.
Keywords: infusion; infusion set; study; day ... See more keywords